You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Eliquis

Showing 1 - 25 of 119
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers, Fasting, Fed Trial in Las Vegas (Apixaban 5 mg Oral Dissolving Film (TAH3311) and Tablet (Eliquis®))

Completed
  • Healthy Volunteers
  • +2 more
  • Apixaban 5 mg Oral Dissolving Film (TAH3311) and Tablet (Eliquis®)
  • Las Vegas, Nevada
    Novum Pharmaceutical Research Services
Aug 15, 2023

Japanese Patients With NonValvular Atrial Fibrillation

Completed
  • NonValvular Atrial Fibrillation
  • Eliquis
  • Toyama-shi, Toyama, Japan
    Local Institution
Jun 3, 2022

Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])

Not yet recruiting
  • Liver Cirrhosis
  • Apixaban 5 MG [Eliquis]
  • Edoxaban 60 MG [Lixiana]
  • (no location specified)
May 19, 2023

Patient Engagement, Patient Satisfaction Trial in Los Angeles (Amazon Alexa based voice recording patient education)

Terminated
  • Patient Engagement
  • Patient Satisfaction
  • Amazon Alexa based voice recording patient education
  • Los Angeles, California
    Cedars Sinai Medical Center
Mar 7, 2022

ELIQUIS Regulatory Post-Marketing Surveillance In Clinical

Completed
  • Venous Thromboembolism
    • Shinjuku-ku, Tokyo, Japan
      Local Institution
    Feb 3, 2022

    Short Bowel Syndrome, Anticoagulation Trial in Leuven (Apixaban single dose)

    Recruiting
    • Short Bowel Syndrome
    • Anticoagulation
    • Apixaban single dose
    • Apixaban steady-state
    • Leuven, Belgium
      University Hospitals Leuven
    Aug 25, 2022

    Venous Thromboembolism Trial in Valhalla (Apixaban)

    Completed
    • Venous Thromboembolism
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022

    Trial in Philadelphia (Apixaban)

    Available
      • Philadelphia, Pennsylvania
        Childrens Hospital Of Philadelphia
      Mar 7, 2022

      Antithrombic Drug Trial in Ahmedabad (Apixaban 5MG, Eliquis 5 mg)

      Completed
      • Antithrombic Drug
      • Apixaban 5MG
      • Eliquis 5 mg
      • Ahmedabad, Gujarat, India
        Lambda Therapeutic Research Ltd.
      Sep 12, 2023

      Venous Thromboembolism Trial (REGN9933, Enoxaparin, Apixiban)

      Not yet recruiting
      • Venous Thromboembolism
      • (no location specified)
      Nov 8, 2022

      Nephrotic Syndrome, Thromboembolic Disease Trial in Aarhus (Dalteparin, Apixaban)

      Recruiting
      • Nephrotic Syndrome
      • Thromboembolic Disease
      • Aarhus, Denmark
        Aarhus University Hospital
      May 20, 2022

      Healthy Trial (Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg)

      Not yet recruiting
      • Healthy
      • Tegoprazan 50mg
      • +3 more
      • (no location specified)
      Feb 2, 2023

      Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

      Recruiting
      • Myeloproliferative Neoplasm
      • +5 more
      • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
      • Aspirin 81 mg
      • Ottawa, Ontario, Canada
        The Ottawa Hospital
      Apr 19, 2022

      COBRRA AF Anticoagulant Trial in Healthcare Claims Data

      Active, not recruiting
      • Atrial Fibrillation
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Mar 25, 2022

      New Oral Anticoagulants in Treatment of Non-valvular Atrial

      Recruiting
      • Atrial Fibrillation
      • Burgos, Spain
      • +5 more
      Jan 2, 2023

      Left Ventricular Thrombus Trial in Dammam (Apixaban, Warfarin)

      Completed
      • Left Ventricular Thrombus
      • Dammam, Saudi Arabia
        Saud AlBabtain Cardiac Center
      Jan 12, 2022

      COBRRA VTE Anticoagulant Trial in Healthcare Claims Data

      Active, not recruiting
      • Venous Thromboembolism
      • +2 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Mar 25, 2022

      Acute Myocardial Infarction, Left Ventricular Thrombosis, Anticoagulants and Bleeding Disorders Trial in Jerusalem (Apixaban

      Completed
      • Acute Myocardial Infarction
      • +2 more
      • Jerusalem, Israel
        Hadassah Medical Organization
      Aug 24, 2021

      Cirrhosis, Splenectomy, Venous Thrombosis Trial in Yangzhou (Apixaban 2.5 MG, Dipyridamole 25Mg Tab, subcutaneous Low Molecular

      Recruiting
      • Cirrhosis
      • +3 more
      • Apixaban 2.5 MG
      • +2 more
      • Yangzhou, Jiangsu, China
        Clinical Medical College, Yangzhou University
      Apr 30, 2022

      Pancreas Cancer, DVT, Pulmonary Embolism Trial in Philadelphia (Apixaban)

      Completed
      • Pancreas Cancer
      • +2 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University Clinical Research Unit
      Dec 6, 2021

      Left Ventricular Thrombosis Trial in Kota Bharu (Apixaban 5 MG Oral Tablet [ELIQUIS], Warfarin Sodium)

      Completed
      Has Results
      • Left Ventricular Thrombosis
      • Apixaban 5 MG Oral Tablet [ELIQUIS]
      • Warfarin Sodium
      • Kota Bharu, Kelanatan, Malaysia
        Hospital Universiti Sains Malaysia
      Jun 15, 2021

      Atrial Fibrillation, Recurrent Venous Thromboembolism Trial in Barcelona (dabigatran, rivaroxaban, apixaban or edoxaban)

      Recruiting
      • Atrial Fibrillation
      • Recurrent Venous Thromboembolism
      • dabigatran, rivaroxaban, apixaban or edoxaban
      • Barcelona, Catalonia, Spain
        Hospital de la Santa Creu i Sant Pau
      Apr 27, 2022

      Atrial Fibrillation Trial in Ottawa (Apixaban, Rivaroxaban)

      Recruiting
      • Atrial Fibrillation
      • Ottawa, Ontario, Canada
        The Ottawa Hospital - General Campus
      Mar 14, 2022

      Oral Anticoagulants Among Obese Non-Valvular A-Fib In VA

      Completed
      Has Results
      • Atrial Fibrillation
      • +2 more
      • New York, New York
        Pfizer
      Oct 28, 2021

      Cirrhosis, Splenectomy; Status, Venous Thrombosis Trial in Yangzhou (Apixaban, Warfarin, Aspirin)

      Recruiting
      • Cirrhosis
      • +3 more
      • Yangzhou, Jiangsu, China
        Clinical Medical College of Yangzhou University
      Mar 19, 2022